NorthRock Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,080
Closed -$275K 707
2025
Q3
$275K Sell
4,080
-1,288
-24% -$102K 0.01% 732
2025
Q2
$469K Sell
5,368
-425
-7% -$33.3K 0.01% 417
2025
Q1
$396K Sell
5,793
-1,864
-24% -$152K 0.01% 409
2024
Q4
$595K Buy
7,657
+4,193
+121% +$310K 0.02% 310
2024
Q3
$232K Sell
3,464
-1,489
-30% -$122K 0.01% 573
2024
Q2
$562K Buy
4,953
+181
+4% +$22.9K 0.02% 312
2024
Q1
$662K Sell
4,772
-25
-0.5% -$3.14K 0.03% 282
2023
Q4
$595K Buy
4,797
+1,969
+70% +$201K 0.02% 277
2023
Q3
$264K Sell
2,828
-375
-12% -$42.3K 0.03% 264
2023
Q2
$412K Sell
3,203
-335
-9% -$40.5K 0.05% 166
2023
Q1
$411K Sell
3,538
-499
-12% -$55.9K 0.04% 169
2022
Q4
$457K Buy
4,037
+981
+32% +$108K 0.05% 170
2022
Q3
$246K Buy
3,056
+162
+6% +$13.7K 0.03% 245
2022
Q2
$216K Buy
2,894
+154
+6% +$14.1K 0.02% 281
2022
Q1
$350K Buy
2,740
+36
+1% +$3.94K 0.03% 221
2021
Q4
$363K Buy
2,704
+316
+13% +$45.4K 0.03% 211
2021
Q3
$326K Buy
2,388
+452
+23% +$57K 0.03% 202
2021
Q2
$207K Buy
+1,936
New +$186K 0.02% 233
2020
Q4
Sell
-2,244
Closed -$231K 237
2020
Q3
$231K Buy
+2,244
New +$234K 0.03% 194

Other funds holding DXCM

NorthRock Partners's DXCM Position: Q4 2025 in Review

NorthRock Partners sold out of DexCom (DXCM) in Q4 2025, closing a stake of 4,080 shares — an estimated $275K sold.

NorthRock Partners first reported a position in DXCM in Q3 2020 and held it in 19 quarters. The position peaked at $662K in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • NorthRock Partners reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • NorthRock Partners sold 4,080 DexCom shares in Q4 2025, an estimated $275K.
  • NorthRock Partners first reported a position in DexCom in Q3 2020 and held it in 19 quarters.
  • NorthRock Partners's DexCom position peaked at $662K in Q1 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.